Publication | Open Access

A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study

Breast OncologyCancer RiskFirst-line ExemestaneMedicineLocally AdvancedBreast CancerProspective StudyOncologyEpidemiology